CL2008002789A1 - Procedimiento para rellenar un espacio tisular debajo de la epidermis que comprende introducir una solucion de monomero funcionalizado, un foto-iniciador por luz visible y opcionalmente un aceptor de protones, un relleno o ambos, y aplicar luego luz visible a la superficie de la piel para formar una red; y composiciones que la contienen. - Google Patents

Procedimiento para rellenar un espacio tisular debajo de la epidermis que comprende introducir una solucion de monomero funcionalizado, un foto-iniciador por luz visible y opcionalmente un aceptor de protones, un relleno o ambos, y aplicar luego luz visible a la superficie de la piel para formar una red; y composiciones que la contienen.

Info

Publication number
CL2008002789A1
CL2008002789A1 CL2008002789A CL2008002789A CL2008002789A1 CL 2008002789 A1 CL2008002789 A1 CL 2008002789A1 CL 2008002789 A CL2008002789 A CL 2008002789A CL 2008002789 A CL2008002789 A CL 2008002789A CL 2008002789 A1 CL2008002789 A1 CL 2008002789A1
Authority
CL
Chile
Prior art keywords
visible light
epidermis
initiator
filler
fill
Prior art date
Application number
CL2008002789A
Other languages
English (en)
Spanish (es)
Inventor
H Elisseeff Jennifer
Hillel Alexander
H Lee Janice
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of CL2008002789A1 publication Critical patent/CL2008002789A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
  • Polymerisation Methods In General (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Moulding By Coating Moulds (AREA)
  • Surgical Instruments (AREA)
CL2008002789A 2007-08-01 2008-09-17 Procedimiento para rellenar un espacio tisular debajo de la epidermis que comprende introducir una solucion de monomero funcionalizado, un foto-iniciador por luz visible y opcionalmente un aceptor de protones, un relleno o ambos, y aplicar luego luz visible a la superficie de la piel para formar una red; y composiciones que la contienen. CL2008002789A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95337507P 2007-08-01 2007-08-01
PCT/US2008/072034 WO2009018555A1 (en) 2007-08-01 2008-08-01 Photoinitiated tissue filler

Publications (1)

Publication Number Publication Date
CL2008002789A1 true CL2008002789A1 (es) 2009-05-29

Family

ID=40304928

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002789A CL2008002789A1 (es) 2007-08-01 2008-09-17 Procedimiento para rellenar un espacio tisular debajo de la epidermis que comprende introducir una solucion de monomero funcionalizado, un foto-iniciador por luz visible y opcionalmente un aceptor de protones, un relleno o ambos, y aplicar luego luz visible a la superficie de la piel para formar una red; y composiciones que la contienen.

Country Status (11)

Country Link
US (2) US8945624B2 (enExample)
EP (1) EP2173296A1 (enExample)
JP (1) JP2010535071A (enExample)
KR (1) KR20100043081A (enExample)
CN (1) CN101790360A (enExample)
AU (1) AU2008283763A1 (enExample)
BR (1) BRPI0814895A2 (enExample)
CA (1) CA2695386A1 (enExample)
CL (1) CL2008002789A1 (enExample)
TW (1) TW201008602A (enExample)
WO (1) WO2009018555A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2707649A1 (en) * 2007-11-02 2009-05-07 Genzyme Corporation Methods of augmenting or repairing soft tissue
WO2012085835A2 (fr) * 2010-12-20 2012-06-28 L'oreal Composition liquide et stérile pour le comblement des rides
FR2988603B1 (fr) * 2012-03-28 2014-04-11 Oreal Composition liquide et sterile pour le comblement des rides.
RU2014147975A (ru) 2012-05-30 2016-07-20 Клокс Текнолоджиз Инк. Композиции и способы биофотонной реконструкции кости
EP2712878A1 (en) 2012-09-28 2014-04-02 Zachodniopomorski Uniwersytet Technologiczny w Szczecinie Telechelic macromers having (meth)acrylic end groups
US9228043B2 (en) 2012-12-27 2016-01-05 Zachodniopomorski Uniwersytet Technology W Szczecinie Application of composition containing telechelic macromer and photoinitiator for producing implant for hernia repair
US9267001B2 (en) 2012-12-27 2016-02-23 Zachodniopomorski Uniwersytet Technologiczny W Szczecinie Telechelic macromer, method for producing telechelic macromer and composition containing telechelic macromer
WO2014105820A1 (en) 2012-12-28 2014-07-03 Boston Scientific Scimed, Inc. Methods, compositions and kits for surgical repair
JP2017509433A (ja) * 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 組織充填剤組成物および使用方法
WO2016065134A1 (en) 2014-10-22 2016-04-28 3M Innovative Properties Company Printed components and methods for making the same
KR102955766B1 (ko) * 2018-05-03 2026-04-22 콜플랜트 리미티드 진피 충전제 및 이의 적용
US11154637B2 (en) * 2018-11-07 2021-10-26 Industrial Technology Research Institute Biodegradable sealant and use of a biodegradable sealant in manufacture of an agent for biological tissue adhesion or repair
TWI754853B (zh) * 2018-11-07 2022-02-11 財團法人工業技術研究院 生物可分解的封合膠與生物可分解的封合膠在製備用於生物組織黏合或修復之試劑中的用途
CN111150878B (zh) * 2018-11-07 2022-03-15 财团法人工业技术研究院 生物可分解的封合胶及其用途
FR3111272A1 (fr) * 2020-06-16 2021-12-17 L'oreal Dispositif d’injection sans aiguille d’une composition photo-polymérisable
CN115947827B (zh) * 2022-10-08 2025-02-18 四川大学 一种重组胶原蛋白及其在软骨修复基质中的用途
KR102905855B1 (ko) * 2024-05-21 2025-12-30 부산대학교 산학협력단 필러 조성물 및 이를 이용한 필러 시술 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US20020088131A1 (en) * 1999-10-08 2002-07-11 Baxa Ronald Dale Syringe dose identification system
EP1610674A4 (en) * 2003-03-13 2008-05-21 Cheryl M Burgess METHODS OF ADMINISTERING MATERIAL TO PATIENT TO OBTAIN DERMAL IMPROVEMENT
WO2006036681A2 (en) 2004-09-22 2006-04-06 Cartilix, Inc. Cartilage filling device
WO2006050110A2 (en) * 2004-10-28 2006-05-11 Surmodics, Inc. Pro-fibrotic coatings comprising collagen for medical implants

Also Published As

Publication number Publication date
JP2010535071A (ja) 2010-11-18
CN101790360A (zh) 2010-07-28
BRPI0814895A2 (pt) 2015-02-03
EP2173296A1 (en) 2010-04-14
TW201008602A (en) 2010-03-01
AU2008283763A1 (en) 2009-02-05
WO2009018555A1 (en) 2009-02-05
US20090074868A1 (en) 2009-03-19
KR20100043081A (ko) 2010-04-27
CA2695386A1 (en) 2009-02-05
US8945624B2 (en) 2015-02-03
US20110002997A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
DOP2012000314A (es) Compuestos, composiciones de tiocetato y metodos de uso
UY31816A (es) Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras
ECSP13011139A (es) Anticuerpos contra la angiopoyetina 2 humana
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
NI201200038A (es) Conjugados de niacina y ácidos grasos y sus usos
CL2011000835A1 (es) Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras.
BRPI0920030A2 (pt) agente de oclusão do tecido
CR10528A (es) Proceso para producir poxvirus y composiciones de poxvirus
CR11731A (es) Composiciones y procedimientos para su preparación y uso
UY30304A1 (es) Moduladores de mglur5 i
MX2009006452A (es) Gel-crema que comprende al menos un retinoide y peroxido de benzoilo.
WO2009076491A3 (en) Remineralizing compositions and methods
UA104133C2 (ru) Прозрачный безводный гель, содержащий ароматизатор
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
AR080495A1 (es) Composicion para el blanqueamiento de los dientes. metodo.
CR20130684A (es) Composición limpiadora que comprende un agente gelificante y un tensioactivo empumante
MX2009006216A (es) Emulsion que comprende al menos un retinoide y peroxido de benzoilo.
GT200500141A (es) Recubrimiento de azucar y metodos para la fabricacion de los mismos.
BR112012028194A2 (pt) composição, e, processo para preparação da composição
CL2009001298A1 (es) Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una enfermedad mediada por la pde4.
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
MX2011004085A (es) Factores sanguineos modificados que comprenden un bajo grado de polimero soluble en agua.
UY30308A1 (es) Moduladores de mglur5 v
PE20120797A1 (es) Derivados de 1-[(3'-fluoro-4'-hidroximetil-5'-metilsulfonil)bifenil-4-il]-2-bencil-4-[(1-hidroxi-1-metil)etil]-1h-imidazol como moduladores de lxr
CL2009000084A1 (es) Compuestos derivados de sulfonamida sustituida, moduladores de receptores de bradiquinina; composicion farmaceutica que contiene a los compuestos; y uso en el tratamiento del dolor agudo, neuropatico o cronico, entre otros.